Literature DB >> 29803791

Enhanced cellular uptake and osteogenic differentiation efficiency of melatonin by inclusion complexation with 2-hydroxypropyl β-cyclodextrin.

Masahiko Terauchi1, Atsushi Tamura2, Satoshi Yamaguchi3, Nobuhiko Yui4.   

Abstract

Melatonin (MLT), a hormone secreted from the pineal gland, is recognized as a potential candidate for stimulation of bone regeneration. However, because of its hydrophobicity, the administration of MLT to stimulate bone regeneration is difficult. In this study, an inclusion complex of MLT with 2-hydroxypropyl β-cyclodextrin (HP-β-CD) was prepared to improve the water solubility, and the osteogenic differentiation ability of the inclusion complex was investigated in MC3T3-E1 cells. The formation of HP-β-CD/MLT inclusion complex was confirmed by 1H and 13C nuclear magnetic resonance spectroscopy and wide-angle X-ray diffraction. The water solubility of MLT increased linearly upon addition of HP-β-CD because of the formation of the inclusion complex. Additionally, treatment of the cells with HP-β-CD/MLT inclusion complex showed higher uptake amount of MLT than that treated with free MLT. In addition, treatment of MC3T3-E1 cells with HP-β-CD/MLT inclusion complex increased alkaline phosphatase activity and mineralized matrix deposition, compared to that in free MLT-treated and untreated cells. Furthermore, cells treated with HP-β-CD/MLT inclusion complex exhibited higher expression levels of osteogenic differentiation genes than those in the untreated and free MLT-treated cells. Accordingly, these results suggested that inclusion complexation of MLT with HP-β-CD would be a potential formulation for bone regeneration because of its improved solubility and enhanced osteogenic differentiation efficiency.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-Hydroxypropyl β-cyclodextrin; Inclusion complex; Melatonin; Osteogenic differentiation

Mesh:

Substances:

Year:  2018        PMID: 29803791     DOI: 10.1016/j.ijpharm.2018.05.063

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

Review 1.  Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.

Authors:  Wamidh H Talib; Ahmad Riyad Alsayed; Alaa Abuawad; Safa Daoud; Asma Ismail Mahmod
Journal:  Molecules       Date:  2021-04-25       Impact factor: 4.411

2.  Polyelectrolyte Complexes between Polycarboxylates and BMP-2 for Enhancing Osteogenic Differentiation: Effect of Chemical Structure of Polycarboxylates.

Authors:  Masahiko Terauchi; Atsushi Tamura; Asato Tonegawa; Satoshi Yamaguchi; Tetsuya Yoda; Nobuhiko Yui
Journal:  Polymers (Basel)       Date:  2019-08-09       Impact factor: 4.329

3.  Non-covalent interactions between sertraline stereoisomers and 2-hydroxypropyl-β-cyclodextrin: a quantum chemistry analysis.

Authors:  Joanatan-Michael Bautista-Renedo; Erick Cuevas-Yañez; Horacio Reyes-Pérez; Rubicelia Vargas; Jorge Garza; Nelly González-Rivas
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 3.361

Review 4.  Melatonin/Cyclodextrin Inclusion Complexes: A Review.

Authors:  Aikaterini Sakellaropoulou; Angeliki Siamidi; Marilena Vlachou
Journal:  Molecules       Date:  2022-01-10       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.